Has anyone heard of this? I heard it is great stuff...
www.zingo.com
Zingotm: The Rapid-Onset Topical Anesthetic
Procedures for blood draws and intravenous (IV) line placements, known as "peripheral venous access procedures," are frequently performed on hospitalized children. In fact, in hospitalized children, peripheral venous access procedures are among the most frequently reported painful events. In 2004, more than 18 million of these procedures were performed on children in hospitals in the United States.
Zingotm (lidocaine hydrochloride monohydrate) powder intradermal injection system provides fast, needle-free topical local analgesia, allowing peripheral venous access procedures to begin one to three minutes after administration in children ages three to 18.
Among Zingo's properties:
? Rapid onset of analgesia in one to three minutes after administration 3, 4
? Simple to use, easy to administer 5
? Needle-free
? In clinical trials, the most common adverse reactions were redness (erythema), red dots (petechiae) and swelling (edema) at the site of administration. 3
Timing is Everything
Before Zingo, available anesthetic creams took 30 to 60 minutes or longer to act. That delay limited use of the creams in the fast-paced hospital environment where time-pressed healthcare providers had to choose between patient comfort and speed when performing peripheral venous access procedures. 6
Zingo delivers sterile lidocaine powder into the skin. It is simple to use and easy to administer, and the venous access procedure can begin within one to three minutes after administration. Zingo's rapid action represents a new alternative for the control of peripheral venous access pain management for children.
Zingo was evaluated in two Phase 3 trials involving more than 1,100 patients in the U.S., demonstrating statistically significant reduction in peripheral venous access pain compared to placebo in children three to 18 years of age. One of these studies was recently published in the prestigious journal Pediatrics. 4
Making Venous Access Pain Management a Reality
The American Pain Society and the American Academy of Pediatrics, among other organizations, have developed recommendations that emphasize the importance of minimizing procedural pain in children whenever possible. 7 However, despite the existence of these recommendations, children undergoing peripheral venous access procedures remain largely under-treated.8 A recent survey of nurses, sponsored by Anesiva, Inc. found that nearly all survey participants (92 percent) agreed that patients and their families would benefit from the use of a fast-acting topical local anesthetic for such procedures.6
www.zingo.com
Zingotm: The Rapid-Onset Topical Anesthetic
Procedures for blood draws and intravenous (IV) line placements, known as "peripheral venous access procedures," are frequently performed on hospitalized children. In fact, in hospitalized children, peripheral venous access procedures are among the most frequently reported painful events. In 2004, more than 18 million of these procedures were performed on children in hospitals in the United States.
Zingotm (lidocaine hydrochloride monohydrate) powder intradermal injection system provides fast, needle-free topical local analgesia, allowing peripheral venous access procedures to begin one to three minutes after administration in children ages three to 18.
Among Zingo's properties:
? Rapid onset of analgesia in one to three minutes after administration 3, 4
? Simple to use, easy to administer 5
? Needle-free
? In clinical trials, the most common adverse reactions were redness (erythema), red dots (petechiae) and swelling (edema) at the site of administration. 3
Timing is Everything
Before Zingo, available anesthetic creams took 30 to 60 minutes or longer to act. That delay limited use of the creams in the fast-paced hospital environment where time-pressed healthcare providers had to choose between patient comfort and speed when performing peripheral venous access procedures. 6
Zingo delivers sterile lidocaine powder into the skin. It is simple to use and easy to administer, and the venous access procedure can begin within one to three minutes after administration. Zingo's rapid action represents a new alternative for the control of peripheral venous access pain management for children.
Zingo was evaluated in two Phase 3 trials involving more than 1,100 patients in the U.S., demonstrating statistically significant reduction in peripheral venous access pain compared to placebo in children three to 18 years of age. One of these studies was recently published in the prestigious journal Pediatrics. 4
Making Venous Access Pain Management a Reality
The American Pain Society and the American Academy of Pediatrics, among other organizations, have developed recommendations that emphasize the importance of minimizing procedural pain in children whenever possible. 7 However, despite the existence of these recommendations, children undergoing peripheral venous access procedures remain largely under-treated.8 A recent survey of nurses, sponsored by Anesiva, Inc. found that nearly all survey participants (92 percent) agreed that patients and their families would benefit from the use of a fast-acting topical local anesthetic for such procedures.6